{"data":{"id":"us/21-cfr-207.45","jurisdiction":"us","citation":"21 CFR 207.45","heading":"When, after initial registration of an establishment, must drug listing information be submitted?","body":"For each drug being manufactured, repacked, relabeled, or salvaged for commercial distribution at an establishment at the time of initial registration, drug listing information must be submitted no later than 3 calendar days after the initial registration of the establishment.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 207—REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE","Subpart D—Listing"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"4e05a323efd830bd374e044d279b42cccb75b1f2cfe5b5ab765861eb1b059778","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-207.41","next":"us/21-cfr-207.49"},"notice":"GroundRules: Original legal text. Not legal advice."}